RxDoctor Payments Data

Christina Snyder

Family · Lakeview, MINPI 1144720939

Payments from drug & device makers

$1,783in general payments, 2019–2025

Across 98 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$259
  • Novo Nordisk$212
  • Astellas Pharma US Inc$147
  • Johnson & Johnson$129
  • Lilly USA, LLC$129
  • AstraZeneca$92
  • plus $816 from 25 others

What the payments were for

  • Food & beverage$1,783100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,783 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide23$31,788
JardianceEmpagliflozin16$27,874
OzempicSemaglutide18$24,401
EliquisApixaban12$16,373
XareltoRivaroxaban11$12,035
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$10,458
Atorvastatin Calcium132$1,704
Albuterol Sulfate HfaAlbuterol Sulfate34$1,700
Omeprazole84$1,635
Rosuvastatin Calcium55$1,476
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen107$1,458
Levothyroxine Sodium133$1,324
Losartan Potassium46$1,024
Venlafaxine Hcl ErVenlafaxine Hcl15$959
Duloxetine Hcl27$936

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$129$31,78823 claims
Boehringer IngelheimJardiance$35$27,87416 claims
Novo NordiskOzempic$212$24,40118 claims
PfizerEliquis$58$16,37312 claims
Johnson & JohnsonXarelto$129$12,03511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.

Other family in Lakeview

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →